Healthcare Analyst Taylor, along with Dr. Nana Sarpong, orthopedic surgeon at Columbia University Medical Center, discuss whether Wegovy will undercut the knee implant market on an Analyst/Industry conference call to be held on February 21 at 11 am. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on NVO:
- Novo Nordisk price target raised to DKK 975 from DKK 875 at BofA
- Weight Loss Drugs Are Slimming Down Grocery Bills
- Short Report: Childrenâs Place bears undeterred by Mithaq Capital involvement
- GLP-1 users’ grocery spending declines 6%-9% after starting, says Morgan Stanley
- Novo Nordisk call volume above normal and directionally bullish